JVM Co

JVM Co Debt / Assets

The Debt-to-Assets Ratio of JVM Co (054950.KQ) as of Nov 4, 2026 is 0.11. In the previous year, Debt-to-Assets Ratio was 0.12 — a change of -7.77% (lower).

Debt / Assets

0.11

YoY

-7.77%

Last updated:

Debt-to-Assets Ratio of JVM Co is 2024 0.11 . Debt-to-Assets Ratio of JVM Co was 2023 0.12 . It decreases by -7.77% lower compared to the previous year.

The JVM Co Debt / Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt / Assets
Date
Debt / Assets
Jan 1, 2017
0.14 KRW
Jan 1, 2018
0.13 KRW
Jan 1, 2019
0.11 KRW
Jan 1, 2020
0.13 KRW
Jan 1, 2021
0.12 KRW
Jan 1, 2022
0.14 KRW
Jan 1, 2023
0.12 KRW
Jan 1, 2024
0.11 KRW
The JVM Co Debt / Assets history
YEARDebt / AssetsYoY
0.11-7.77%
0.12-11.46%
0.14+16.17%
0.12-11.22%
0.13+23.55%
0.11-15.60%
0.13-11.68%
0.14-37.27%
0.23+7.30%
0.21-23.77%
0.28—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

Debt-to-Assets Ratio of JVM Co is 0.11 in 2024.

Debt-to-Assets Ratio of JVM Co changed from 0.12 to 0.11, representing a -7.77% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt-to-Assets Ratio JVM Co since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Assets ratio measures what percentage of a company's assets are financed through debt. Higher ratios indicate greater financial risk.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Assets Ratio's JVM Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — JVM Co

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — JVM Co